Quest Diagnostics Total Liabilities 2010-2024 | DGX

Quest Diagnostics total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • Quest Diagnostics total liabilities for the quarter ending March 31, 2024 were $7.485B, a 11.62% increase year-over-year.
  • Quest Diagnostics total liabilities for 2023 were $7.68B, a 11.19% increase from 2022.
  • Quest Diagnostics total liabilities for 2022 were $6.907B, a 3.1% decline from 2021.
  • Quest Diagnostics total liabilities for 2021 were $7.128B, a 1.23% decline from 2020.
Quest Diagnostics Annual Total Liabilities
(Millions of US $)
2023 $7,680
2022 $6,907
2021 $7,128
2020 $7,217
2019 $7,156
2018 $5,736
2017 $5,548
2016 $5,440
2015 $5,249
2014 $5,527
2013 $4,975
2012 $5,098
2011 $5,598
2010 $4,474
2009 $4,552
Quest Diagnostics Quarterly Total Liabilities
(Millions of US $)
2024-03-31 $7,485
2023-12-31 $7,680
2023-09-30 $7,019
2023-06-30 $7,138
2023-03-31 $6,706
2022-12-31 $6,907
2022-09-30 $6,951
2022-06-30 $6,862
2022-03-31 $7,027
2021-12-31 $7,128
2021-09-30 $7,140
2021-06-30 $6,921
2021-03-31 $7,141
2020-12-31 $7,217
2020-09-30 $7,697
2020-06-30 $7,109
2020-03-31 $6,346
2019-12-31 $7,156
2019-09-30 $6,365
2019-06-30 $6,251
2019-03-31 $6,596
2018-12-31 $5,736
2018-09-30 $5,621
2018-06-30 $5,484
2018-03-31 $5,629
2017-12-31 $5,548
2017-09-30 $5,611
2017-06-30 $5,438
2017-03-31 $5,446
2016-12-31 $5,440
2016-09-30 $5,479
2016-06-30 $5,540
2016-03-31 $5,431
2015-12-31 $5,249
2015-09-30 $5,453
2015-06-30 $5,376
2015-03-31 $6,342
2014-12-31 $5,527
2014-09-30 $5,591
2014-06-30 $5,638
2014-03-31 $5,530
2013-12-31 $4,975
2013-09-30 $5,056
2013-06-30 $5,098
2013-03-31 $5,079
2012-12-31 $5,098
2012-09-30 $5,121
2012-06-30 $5,372
2012-03-31 $5,555
2011-12-31 $5,598
2011-09-30 $5,782
2011-06-30 $5,981
2011-03-31 $5,987
2010-12-31 $4,474
2010-09-30 $4,579
2010-06-30 $4,535
2010-03-31 $4,587
2009-12-31 $4,552
2009-09-30 $4,428
2009-06-30 $4,446
2009-03-31 $4,814
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.437B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.911B 0.00
DaVita (DVA) United States $12.399B 15.40
Elanco Animal Health (ELAN) United States $8.920B 23.14
Encompass Health (EHC) United States $8.544B 21.87
Chemed (CHE) United States $8.213B 25.46
Option Care Health (OPCH) United States $4.898B 18.54
RadNet (RDNT) United States $4.340B 90.37
Amedisys (AMED) United States $2.999B 21.24
Astrana Health (ASTH) United States $2.312B 31.26
LifeStance Health (LFST) United States $2.022B 0.00
Addus HomeCare (ADUS) United States $1.939B 27.74
U.S Physical Therapy (USPH) United States $1.388B 37.15
Pennant (PNTG) United States $0.677B 35.75
Aveanna Healthcare Holdings (AVAH) United States $0.492B 0.00
Atai Life Sciences (ATAI) Germany $0.224B 0.00
Daxor (DXR) United States $0.043B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.024B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Novo Integrated Sciences (NVOS) United States $0.016B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00